The NJ Mass Spectrometry Discussion Group is pleased to announce our June 18, 2024 in-person Meeting, sponsored by Biognosys

5:30 PM    Social and Registration
6:15 PM    Complimentary Dinner
6:55 PM    Welcome and Opening Remarks

7:05 PM  Speaker 1:   Todd Hembrough, PhD, CEO and Co-Founder Nexosome Oncology, Identification of early-stage NSCLC biomarkers from extracellular vesicle microenvironment identifies tumor and immune response biomarkers associated with cancer, Abstract

8:00 PM Speaker 2:   Valesca Anshau, Scientific Director for North America for Biognosys;  Unveils Enhanced Plasma Proteomics for High-Throughput Biomarker Discovery, Abstract